Treatment of addiction and impulse-control disorders using PDE7 inhibitors
US-9220715-B2 · Dec 29, 2015 · US
Transient protection of hematopoietic stem and progenitor cells against ionizing radiation
US2018303838A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018303838-A1 |
| Application number | US-201715839685-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 12, 2017 |
| Priority date | Mar 15, 2013 |
| Publication date | Oct 25, 2018 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention is in the area of improved compounds and methods for transiently protecting healthy cells, and in particular hematopoietic stem and progenitor cells (HSPC), from the damage associated with ionizing radiation (IR) exposure using selective radioprotectants.
First claim
Opening claim text (preview).
1 . A pharmaceutical composition comprising an effective amount of a compound having the formula: wherein R is C(X) 2 , wherein the two X groups together form an alkyl bridge to form a spiro compound; or its pharmaceutically acceptable salt thereof; in a pharmaceutically acceptable carrier.
Assignees
Inventors
Classifications
ortho- or peri-condensed with heterocyclic rings · CPC title
Growth factors; Growth regulators · CPC title
IL-12 · CPC title
Shielding, protecting against radiation · CPC title
Colony stimulating factors [CSF] · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2018303838A1 cover?
- This invention is in the area of improved compounds and methods for transiently protecting healthy cells, and in particular hematopoietic stem and progenitor cells (HSPC), from the damage associated with ionizing radiation (IR) exposure using selective radioprotectants.
- Who is the assignee on this patent?
- G1 Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/527. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Oct 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).